Livzon Pharmaceutical Group Inc
SZSE:000513
Livzon Pharmaceutical Group Inc
Cash from Operating Activities
Livzon Pharmaceutical Group Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Livzon Pharmaceutical Group Inc
SZSE:000513
|
Cash from Operating Activities
¥3.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
21%
|
CAGR 10-Years
22%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Operating Activities
¥2.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Operating Activities
¥3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
108%
|
CAGR 10-Years
30%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Operating Activities
¥3.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Operating Activities
¥3.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Cash from Operating Activities
¥927.2m
|
CAGR 3-Years
38%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
See Also
What is Livzon Pharmaceutical Group Inc's Cash from Operating Activities?
Cash from Operating Activities
3.2B
CNY
Based on the financial report for Dec 31, 2023, Livzon Pharmaceutical Group Inc's Cash from Operating Activities amounts to 3.2B CNY.
What is Livzon Pharmaceutical Group Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
22%
Over the last year, the Cash from Operating Activities growth was 17%. The average annual Cash from Operating Activities growth rates for Livzon Pharmaceutical Group Inc have been 15% over the past three years , 21% over the past five years , and 22% over the past ten years .